Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alere Inc. stock logo
ALR
Alere
$1.32
$0.00
$34.41
$51.00
$43.05M0.8540,839 shsN/A
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
$1.32
$1.32
$2.72
$9.25
$41.91M1.0363,028 shsN/A
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
$1.28
+2.3%
$1.26
$0.85
$3.13
$33.64M0.46159,520 shs20,718 shs
United-Guardian, Inc. stock logo
UG
United-Guardian
$8.25
+2.3%
$8.77
$7.73
$16.25
$37.88M0.9513,376 shs6,978 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alere Inc. stock logo
ALR
Alere
0.00%0.00%0.00%0.00%0.00%
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
0.00%0.00%0.00%0.00%0.00%
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
0.00%-2.34%+14.68%+37.09%-59.55%
United-Guardian, Inc. stock logo
UG
United-Guardian
0.00%+0.62%-1.35%-25.71%-4.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alere Inc. stock logo
ALR
Alere
N/AN/AN/AN/AN/AN/AN/AN/A
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
N/AN/AN/AN/AN/AN/AN/AN/A
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
2.4041 of 5 stars
3.05.00.00.03.30.00.6
United-Guardian, Inc. stock logo
UG
United-Guardian
2.9252 of 5 stars
0.05.01.70.03.41.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alere Inc. stock logo
ALR
Alere
0.00
N/AN/AN/A
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
0.00
N/AN/AN/A
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
2.00
Hold$3.17147.61% Upside
United-Guardian, Inc. stock logo
UG
United-Guardian
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest FVE, ALR, UG, and LVTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/31/2025
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.50 ➝ $1.50
2/27/2025
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$2.00 ➝ $1.50
(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alere Inc. stock logo
ALR
Alere
$934.59M0.05N/AN/A$5.72 per share0.23
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
$1.04B0.04$0.29 per share4.54$6.67 per share0.20
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
$11.98M2.81N/AN/A$1.95 per share0.66
United-Guardian, Inc. stock logo
UG
United-Guardian
$12.18M3.11$0.45 per share18.48$2.48 per share3.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alere Inc. stock logo
ALR
Alere
-$29.92M-$1.20N/AN/AN/A-5.34%-20.78%-9.02%N/A
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
-$7.59M-$0.52N/AN/AN/A-1.57%-4.25%-1.99%N/A
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
-$41.97M-$0.93N/AN/AN/AN/A-62.22%-29.37%5/20/2025 (Estimated)
United-Guardian, Inc. stock logo
UG
United-Guardian
$2.58M$0.7110.85N/A28.30%30.25%26.26%N/A

Latest FVE, ALR, UG, and LVTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
-$0.37N/AN/AN/AN/AN/A
5/8/2025Q1 2025
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A$0.12N/A$0.12N/A$2.48 million
3/28/2025Q4 2024
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
-$0.32-$0.14+$0.18-$0.14$2.40 million$2.50 million
3/21/2025Q4 2024
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A$0.11N/A$0.11N/A$2.48 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alere Inc. stock logo
ALR
Alere
N/AN/AN/AN/AN/A
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
N/AN/AN/AN/AN/A
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
N/AN/AN/AN/AN/A
United-Guardian, Inc. stock logo
UG
United-Guardian
$0.708.49%-26.43%98.59%1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alere Inc. stock logo
ALR
Alere
0.45
1.58
1.58
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
0.05
1.51
1.51
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
N/A
5.36
5.36
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A
6.66
6.02

Institutional Ownership

CompanyInstitutional Ownership
Alere Inc. stock logo
ALR
Alere
24.08%
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
34.10%
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
N/A
United-Guardian, Inc. stock logo
UG
United-Guardian
23.16%

Insider Ownership

CompanyInsider Ownership
Alere Inc. stock logo
ALR
Alere
8.40%
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
7.00%
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
0.79%
United-Guardian, Inc. stock logo
UG
United-Guardian
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alere Inc. stock logo
ALR
Alere
10,40032.61 million29.87 millionOptionable
Five Star Senior Living Inc. stock logo
FVE
Five Star Senior Living
19,00031.75 million29.53 millionOptionable
LAVA Therapeutics stock logo
LVTX
LAVA Therapeutics
6026.31 million26.08 millionOptionable
United-Guardian, Inc. stock logo
UG
United-Guardian
204.59 million3.26 millionNot Optionable

Recent News About These Companies

United-Guardian Reports First Quarter Results
United-Guardian Reports 2024 Financial Results
United-Guardian Declares Cash Dividend
(UG) Trading Signals
When the Price of (UG) Talks, People Listen
(UG) Long Term Investment Analysis
Trading (UG) With Integrated Risk Controls
United-Guardian Posts Rising Q3 Earnings
United-Guardian Reports Increased Third Quarter Earnings
Learn to Evaluate (UG) using the Charts
Gold Rises on Possible Technical Recovery
(UG) Investment Report

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alere stock logo

Alere NYSE:ALR

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Five Star Senior Living stock logo

Five Star Senior Living NASDAQ:FVE

Five Star Senior Living, Inc. engages in the senior living operations. It operates through the following segments: Senior Living Communities & Rehabilitation and Wellness. The Senior Living Communities segment owns account or manages the account of others independent living communities, assisted living communities, and skilled nursing facilities that are subject to centralized oversight, and provide housing and services to elderly residents. The Rehabilitation and Wellness segment offers physical, occupational, speech, and other specialized therapy services, in the inpatient setting and in outpatient clinics. The company was founded by Barry Michael Portnoy and Gerard Michael Martin in April 2000 and is headquartered in Newton, MA.

LAVA Therapeutics stock logo

LAVA Therapeutics NASDAQ:LVTX

$1.28 +0.03 (+2.31%)
Closing price 03:59 PM Eastern
Extended Trading
$1.26 -0.02 (-1.48%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.

United-Guardian stock logo

United-Guardian NASDAQ:UG

$8.24 +0.19 (+2.30%)
Closing price 03:53 PM Eastern
Extended Trading
$8.24 -0.01 (-0.12%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.